-
Interview with Chief Medical Advisor Dr Cathryn Clary
Read more: Interview with Chief Medical Advisor Dr Cathryn ClaryJuly 22, 2024
-
Proactive Investors – Percheron continues to advance Duchenne treatment
Read more: Proactive Investors – Percheron continues to advance Duchenne treatmentMarch 6, 2024
-
Antisense Therapeutics Annual General Meeting 2023 Presentation
Read more: Antisense Therapeutics Annual General Meeting 2023 Presentation15 November 2023
-
Antisense Therapeutics presents to ShareCafe Hidden Gems
Read more: Antisense Therapeutics presents to ShareCafe Hidden Gems8 September 2023
-
Antisense Therapeutics Open House (Melbourne)
Read more: Antisense Therapeutics Open House (Melbourne)28 August 2023
-
Corporate Presentation
Read more: Corporate PresentationAugust 2023 Download PDF